Menu Search
Equities

CareRx Corp

29C1:DEU

CareRx Corp

Actions
  • Price (EUR)1.53
  • Today's Change-0.03 / -1.92%
  • Shares traded0.00
  • 1 Year change+2.68%
  • Beta--
Data delayed at least 15 minutes, as of May 03 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

CareRx Corporation is a Canada-based provider of pharmacy services to seniors living communities. The Company serves over 94,000 residents in over 1,500 senior and other congregate care communities, including long-term care homes, retirement homes, assisted living facilities, and group homes. It supports its home care partners by providing solutions for the supply of chronic medication. It offers a range of medication solutions. Its technology automates the preparation and verification of multi-dose compliance packaging of medication, providing the safety and adherence for individuals with complex medication regimes. Its network of pharmacy fulfillment centers delivers solutions for the supply of chronic medication and other specialty clinical pharmacy services. The Company provides services in rural and urban areas throughout Ontario, Alberta, British Columbia, and parts of Saskatchewan. It works with home operator partners to promote resident health, staff education and others.

  • Revenue in CAD (TTM)370.75m
  • Net income in CAD-5.41m
  • Incorporated2017
  • Employees1.44k
  • Location
    CareRx Corp320 Bay St. Suite 1200TORONTO M5H 4A6CanadaCAN
  • Phone+1 (647) 361-4499
  • Fax+1 (416) 927-8405
  • Websitehttps://www.carerx.ca/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.